Filing Details
- Accession Number:
- 0001077183-20-000209
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-12 18:00:24
- Reporting Period:
- 2020-11-10
- Accepted Time:
- 2020-11-12 18:00:24
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1077183 | Neogenomics Inc | NEO | Services-Testing Laboratories (8734) | 742897368 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1804602 | E Denise Pedulla | 12701 Commonwealth Drive Suite 9 Fort Myers FL 33913 | General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-11-10 | 15,000 | $7.85 | 58,988 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-11-10 | 2,262 | $42.00 | 56,726 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-11-10 | 15,000 | $0.00 | 15,000 | $7.85 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2020-12-08 | No | 4 | M | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | $7.52 | 2022-04-28 | 25,000 | 25,000 | Direct | |
| Common Stock | Stock Option (Right to Buy) | $8.03 | 2023-02-26 | 48,334 | 48,334 | Direct | |
| Common Stock | Stock Option (Right to Buy) | $19.60 | 2024-03-01 | 17,496 | 17,496 | Direct | |
| Common Stock | Stock Option (Right to Buy) | $28.33 | 2027-03-02 | 18,757 | 18,757 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2022-04-28 | 25,000 | 25,000 | Direct |
| 2023-02-26 | 48,334 | 48,334 | Direct |
| 2024-03-01 | 17,496 | 17,496 | Direct |
| 2027-03-02 | 18,757 | 18,757 | Direct |
Footnotes
- On December 8, 2015, Ms. Pedulla was granted 60,000 stock options. These options vested ratably over the first four anniversary dates of the grant date.
- On April 28, 2017, Ms. Pedulla was granted 75,000 stock options. These options vested ratably over the first three anniversary dates of the grant date.
- On January 26, 2018, Ms. Pedulla was granted 72,500 stock options. These options vest ratably over the first three anniversary dates of the grant date.
- On March 1, 2019, Ms. Pedulla was granted 17,496 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- On March 2, 2020, Ms. Pedulla was granted 18,757 stock options. These options vest ratably over the first four anniversary dates of the grant date.
Billionaire Hedge Funds
